Ravelcare Limited has scheduled a meeting of its Board of Directors to be held on Saturday, May 30, 2026, at the company's registered office. The primary agenda for this meeting is to consider and approve the Audited Financial Results of the Company for both the half year and financial year ended on March 31, 2026, along with the Audit Report for the corresponding period.
In accordance with the company's Code of Conduct for prohibition of insider trading, the Trading Window for dealing/trading in the company's shares has been closed since April 1, 2026. The trading window will remain closed until 48 hours after the conclusion of the Board Meeting.
This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was digitally signed by Alpesh Bhatt, who serves as both Company Secretary and Compliance Officer of Ravelcare Limited.